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On the basis of MIC90 criteria, vancomycin was 2-4 times more 
active than teicoplanin against staphylococci whereas teicoplanin was 
at least two fold more active against streptococci. Teicoplanin was 
generally four to eight fold more active than vancomycin against the 
majority of Enterococcus spp. The incidence of enterococci resistant 
to teicoplanin (0.62%) and vancomycin (0.93%) was low. 
F1 Activity of Teicoplanin, Vancomycin and 8 Other 
Drugs Against Gram-Positive Pathogens Isolated 
in Italy 
G.C. Schito, A. Pesce, A. Marchese, E.A. Debbia for the Italian 
Glycopeptide Resistance Group. Institute tfMicrobiobBy, School .f 
Medicine, University .f Genoa, Italy 
At present only the glycopeptides teicoplanin and vancomycin re- 
tain, in most sites, a consistent activity against multi-drug resistant 
Gram-positive pathogens responsible for serious infections in the 
community and in n o s o c o d  settings. Thus, monitoring their con- 
tinuous efficacy becomes essential since the clinicians are accustomed 
to use these drugs on an empirical basis. In 1995 a large multicenter 
study enrolling 70 laboratories in 9 European countries has analysed 
6824 Gram-positive isolates for susceptibility to the two glycopep- 
tides. In Italy, besides teicoplanin and vancomycin, the in vifro ac- 
tivity of several other relevant drugs was assessed by an agar dilution 
method (NCCLS) on the collection of strains (807) sent to this coor- 
ha t ing  laboratory. Percent susceptible organisms at the breakpoints 
(NCCLS, 1995) are reported in the table for the antibiotics tested 
Pathogen X Surccpnble orguusms to 
n amp pen cef 1m net ery nor cip CCL vul 
Staph. (MS) 280 32.5 100 1W 95 51 75 69 100 100 
Staph. (MR) 219 80 10 14 10 99.6 100 
E. faemfu 247 87 94 66 42 99.6 99.6 
E. fam'um 46 28 43 52 17 100 98 
Thts  SUN^ confirms that teicoplanin is more active than van- 
comycin on Enterococci and that it displays in practice comparable 
potency against the Staphylococci. In accordance with the data ob- 
tained in other countries it may be concluded that usage of the two 
glycopeptides, as occurring in Europe, may delay the appearance and 
spread of glycopeptide-resistant Gram-positive pathogens as experi- 
enced in other regions of the world where only one molecule is 
employed. One possible mechanism for this may be ascribed to the 
fact that vancomycin can easily induce organisms carrying the VanB 
phenotype to f d  blown resistance while teicoplanin is devoid of this 
untoward effect. 
[p7311 Emergence of Fluoroquinolone Resistance in 
M. Kresken, D. Hafher for the Study Group. Paul-Ehrlich-Son'etyfor 
Chemotherapy, Study Group 'Bacterial Resistance', Cologne, &any 
Objectives: To evaluate the influence of an increasing consumption 
of fluoroquinolones on the prevalence of fluoroquinolone resistance 
in chical isolates of fiequently encountered bacterial species. 
Methods: The susceptibility data b m  4 collaborative Studies 
(each comprising more than 20 centres) conducted in 1983 (prior to 
the introduction of any fluoroquinolone), 1986 (after introduction 
of norfloxacin and ofloxacin in Germany), 1990 (after introduction 
of ciprofloxacin in Germany), and 1995 were analyzed. Uniform 
standard methods for idenbfication of the bacteria and susceptibility 
testing were used. MICs were determined by the broth microdi- 
lution method. A total of 14,960 strains were under investigation. 
Data are presented for ciprofloxacin regarded as a representative flu- 
oroquinolone. 
Results: Considering 2 4  mg/l as a breakpoint for resistance to 
ciprofloxacin the incidence of resistant s t r a i n s  of Enterobacterimeae 
remained below 1% until 1990, but increased to 3.8% (E. coli 5.2%) 
in 1995. The resistance rates in I! aeruginosa were 0.7%. 1%, 6.4%, 
and 11.9%, in S. aureus 0%. 0.5%, 6.2%, and 12.8%, and in E.faecalis 
2.2%, 0.7%, 7.7%, and 28.9%. The resistance rate in CNS increased 
b m  19.6% (1990) to 44.5% (1995). In the latest study E .  faen'um, 
M R S A ,  and M R - C N S  had the highest resistance rates (73.1%, 89.6% 
and 69.8%, respectively). 
Conclusions: The increasing consumption of fluoroqinolones 
seems to select resistant populations. Fluoroquinolone resistance has 
emerged in Central Europe. 
Central Europe 
Multicenter Survey of Eschenchia coli Resistant 
to Ciprofloxacin: Analysis of Clonal Diversity 
and Gyrase Mutation 
C. Nonhoff:', M. Delm&e*, MJ Struelens' for the Multicenter 
Study Group. 'Laboratoire de Microbiologie, HGpital Erasme, UniversitC 
Libre de Bruxelles, Belgium, Unid  de Microbiologie, HGpital St. LAC, 
Universid Cathofique de Louvain, Brussels, Belgium 
Objectives: To determine the rate of ciprofloxacin (CIP) resistance 
by using the ATI3 system in E .  coli isolates collected from two mul- 
ticenter surveys of l l Belgian hospitals and to define clonal diversity 
and gyrase mutation in CIP-E. coli isolates. 
Methods: CIP-R isolates were analysed by genomic typing (Ar- 
biuary Primer-PCR analysis using ERIClR and ERIC2 primers 
and PFGE analysis using XbaI). Detection of gyrA codon 83 mu- 
tation was done by using PCR amplification of the gyrA QRDR 
region and H i n j  RFLP analysis. 
Results: The rate of CIP-R in E. coli isolates increased from 
121520 (2%) in 1991 to 27/504 (5%) in 1993 (p -= 0.01). CIP 
MICs ranged &om 4 to 64 wg/ml. AP-PCR analysis discriminated 
14 genotypes and PFGE typing delineated 15 major types among 
23 a d b l e  CIP-R isolates fiom 1993 survey. Genotypes appeared 
geographically dispersed. All CIP-R isolates exhibited the most fie- 
quently reported mutation in codon 83 ofByrA. 
Conclusions: These data indicate that CIP resistance is increas- 
ing among'E. coli isolates b m  hospitalized patients in Belgium. 
Genomic diversity suggests that polyclonal emergence of CIP-R 
mutants is the predominant mechanism. Although a common ByrA 
mutation was found in CIP-R strains, the presence of additional 
mutations in gyrA and/or p a C  genes may explain the high resistance 
displayed by the majority of strains. 
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I P733] Accumulation of Fluoroquinolones (FQ) in 
Acinetobacter baumannii (Ab) 
I. L6pez-Hernandez ', L. Martinez-Martinez lS2, A. Pascual'*'. 
1.1. Garcia2, EJ. Perea','. 'Dpt. ofMinobiology, Univ. Hosp. K 
Macarena, Seville, Spain, 2School $Medicine, Seville, Spain 
Objectives: To evaluate the relationshp between accumulation and 
activity of FQ in d o d y  non-related c h c a l  isolates of Ab. 
Methods: Six strains of Ab corresponding to different pulse-field 
gel electmphoresis types were used. MICs of nodoxacin (NOR) 
and pefloxacin (PFX) were determined by microdilution (NCCLS). 
Two sets of 500 pL of cells in PBS (4°C; 1.5 A550 U/ml) and FQ 
(10 mg/L) were incubated with shaking for 10 min at 37'C. Cells 
(500 pL) fium the first set were added to a new tube containing 500 
pL of silicon oil (p:  1.029); the second set of tubes was washed twice 
with 1-mL of cold PBS. Cells were collected by centrifugation. Two 
mL of 0.1M glycine-HC1 (PH 3.0) were added to each pellet; cells 
were disrupted by vortexing and overnight incubation (25°C). Cell 
debris was removed by centrifugation (4'C, 13,000 rpm, 5 rnin) and 
the amount of FQ was determined by fluorescence emission of the 
supernatant at 445 nm (NOR) or 441 nm (PFX). 
Results: MICs (mg/L) and accumulation (ng/mg dry weight of 
cells) were: 
Strain 
12 104 30 14 32 55 
NOR MIC 1024 64 64 64 4 4 
PFX MIC 64 16 8 4 0.25 0.125 
ACCUM. 279 f 6 349 f 2 4  287 f 17 429 f 17 267 f 40 385 f 20 
ACCUM. 297*45 4 4 9 f 5 4  225f 12 410f  13 291 f 4 4  237f20 
In assays without silicon oil, lower values of accumulation were 
obtained. 
Conclusions: The activity of NOR and PFX against Ab is not 
directely related to the degree of accumulation of these drugs in the 
organism. 
I P734 1 Ciprofloxacin Resistant Campylobacter Species 
in Styria, Austria 
G. Feierl, Ch. Berghold', T. Fiirpass2, A. Grisold, S. Greimel, 
B. Sixl, U. Eibel, E. M a d .  Hygiene-lnstitut, Grar, Austria, 
' BBSUA, Graz,  Austria, 'Bakt. Lnbor des Parhologischen Instihtts, 
LKH Leoben, Austria 
Objectives: Salmonella and Campylobacter species are the most sig- 
nificant diarrhea-causing pathogens in our region. In 1996 about 
30.000 stool specimen were tested in the three most important bac- 
teriological laboratorys in Styria (Austria). The mean isolation rate 
of Campylobacterjejuni/coli was 2.18%. 653 isolates from 571 patients 
were found. Distribution of these isolates shows a high prevalence in 
the age group from 0-10 years. 
Method: To evaluate the ciprofloxacin resistance all isolates were 
tested routinely with agar difhsion, 100 s t r a i n s  were additionally 
tested by the E-test. 
Result: The aprofloxacin resistance rate was 25.2%. The distri- 
bution in the different age groups shows no sigdicant difference. 
Conclusion: Empirical therapy of Campylobacrer infection with 
ciprofloxacin is not justified in our region. The high rate of 
ciprofloxacin resistance requires a routine susceptibility testing, also 
to venfy further resistance development. The antibiotic of choice re- 
mam erythromycin with a s t i l l  low resistance rate (1.4%). The use of 
enrofloxacin in veterinary medicine should be handled restrictively. 
I P735 I Characterization of Quinolone-Resistant Clinical 
J. Ruiz, €? Goiii, E Marco, M.T. Jimtnez de Anta, J. Vila. 
Departament de Microbiologia, Hospital Clinic, School of Medicine, 
University of Barcelona, Spain 
Objective: The quinolone-resistance mechanisms are classtfied into 
three major categories: Target mutations, permeability alterations or 
overexpression of efflux pumps. The aim of this study was to estabhh 
which of these mechanism were present in four quinolone-resistant 
clinical isolates of Citrobacterfreundii. 
Methods: Eight clinical isolates of Citrobacterfreundii with a range 
of ciprofloxacin MIC fium 50.007 to 32 pg/ml and 5 2  to > 1024 
pg/ml for nalidixlc acid were chosen. 
Using conserved amino acid sequence moo& found in several 
GyrA and ParC proteins, two sets of primers were designed. The 
PCR products were recovered and directly sequenced. 
Results: All the resistant st ra ins  showed a h& nalidudc acid re- 
sistance level (MIC ? 1024 pg/ml) No mutations were observed in 
the gyrA and patC genes of the four quinolone susceptible strains, 
whereas all the quinolone resistant strains showed mutations in 
these genes. Three of these strains (ciprofloxacin MIC 8-32 pg/ml) 
showed a concomitant mutation Ser-83 to Ile and Asp-87 to Tyr in 
GyrA and Ser-80 to Ile in ParC. The fourth (ciprofloxacin MIC 16 
lg/ml) showed a mutation Ser-83 to Ile in the GyrA and Ser-80 to 
Ile in ParC. 
Conclusion: Mutations in gyrA and patC genes plays an impor- 
tant role in the acquisition of quinolone resistance in c h c a l  isolates 
of Citrobacterfreundii. 
Isolates of Citrobacter tieundii 
Molecular Analysis of Quinolone Resistance in 
Woddwide Isolates of Acinetobacter baumannii 
RJ. Seward, KJ. Towner. Dept. ofMinobiolqy G P H L S  Laboratory, 
University Hospital, Nottingham NC7 ZUH,  UK 
Objective: To determine the molecular basis of resistance to 
quinolones in Acinetobacrer baumannii isolates fium various countries 
of the world. 
Methods: Quinolone resistance in bacteria has been associated 
with specific mutations in the gyrA and parC genes. To determine 
whether such mutations are common in A. baumannii, 12 resis- 
tant clinical isolates (MICs of nalididc acid, 256->lo24 m g L  
ciprofloxacin, 1-64 mg/L) fium 8 different countries were first char- 
acterised by biotyping, D N A  fingerprinting and random-primed 
(RAPD) fingerprinting. Conserved regions encompassing the active 
sites of the gyrA and parC genes were then amphfied by PCR and 
analysed by restriction endonuclease digestion and DNA sequenc- 
Results: RAF'D fingerprinting demonstrated that the 12 iso- 
lates were genetically unrelated. PCR amplification yielded 342-bp 
and 327-bp products, respectively, from the conserved gyrA and 
parC regions of each strain. H i d  kgestion of the amplified re- 
gions fium quinolone-sensitive st ra ins  yielded two hgments in each 
case because of Hinfl restriction sites at Asp82-Ser83 in gyrA and 
Asp79-Ser80 in parC. All 12 resistant isolates had lost the H i d  re- 
striction site in gyrA,  in most cases following a mutation of Ser83 
to Leu. Five of the 12 isolates also had a mutation at Ser80 in the 
conserved region o f p a r C .  
Conclusions: Highly simjlar mutations to quinolone resistance 
occur in unrelated strains of A.  baumannii isolated worldwide. All 
resistant isolates examined had mutations in the gyrA gene, but sec- 
ondary mutations in the parC gene were found in isolates with the 
highest quinolone MICs. 
ing. 
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I P737 I Emergence of Resistant fseudomonas 
aeruginosa during lmipenem (IMP) vs 
Piperacillin-Tazobactam (Pn) Therapy 
N. Trodlet , C. Jaccard ', A. Cometta ', J. Bille ', M.P. Glauser '. 
' I C H Y  Sion, Switzerland, 'CHLlY Lausanne, Switzerland 
Objectives: To compare the rates of emergence of resistant Pseu- 
domonas aeruginosa (Pa) in patients (pts) treated with IMP or with 
P/T. 
Methods: Case-control study nested in a randomized dinical trial 
of PIT 4.5 g tid vs IMP 0.5 g qid to treat 313 pts with nosocomial 
pneumonia or acute peritonitis. Cases were pts with Pa susceptible to 
both drugs at randomization (duk-&sion testing) and subsequent 
clinical detection of Pa resistant to the drug they were on (same cul- 
ture site). Controls were pts with susceptible Pa at randomization and 
with lack of subsequent resistant isolates. Univariate and multivariate 
(logistic regression) analyses were performed. 
Results: 13 cases and 40 controls were identified. In univariate 
analysis, exposure to IMP resulted more often in detection of re- 
sistant Pa than exposure to P/T (11128, 39% vs 2/25, 8%) (Odds 
Ratio = 7.4, p = 0.01). The APACHE I1 scores were higher in cases 
than in controls (p = 0.09). No s i d c a n t  difference was found be- 
tween cases and controls for sex, age, weight, disease (pneumonia vs 
peritonitis), days of treatment, days of mechanical ventilation, prior 
surgical procedures, prior antibiotic treatments, and bacteremic or 
polymicrobial mfections. Pts on IMP had not been cultured sign&- 
candy more often than pts on P/T. Multivariate analysis confirmed 
the Merence in antibiotic exposures while controlling for APACHE 
I1 scores (OR = 6.3, p = 0.03). 
Conclusions: Resistant I! amginosa (whether same or new 
strains) emerged more often during IMP therapy than during P/T 
therapy. Since no systematic surveillance was performed, the rates 
might be higher for both drugs. 
1 P738 1 Evolution of the Antimicrobial Resistance in 
T. Pelaez, E. Miranda, P Mu~ioz, P Gijon, R. Alonso, 
M. Rodriguez-Creixems, E. Bouza. Hospital General "Gregorio 
Mararion", Madrid, Spain 
Objectives: To anahze the antimicrobd resistance in Haemophilus 
spp. isolates during a five years period. 
Methods: From January, 1991 to March, 1995 we registered in 
our department a total of 1004 Haemphilus isolates obtained from 
c h c a l  samples. The isolation site frequencies were, 45% from respi- 
ratory tract, 25% h m  conjunctival swabs, 10% from otical swabs, 6% 
fxom blood and 14% from other sources. Antimicrobid susceptibility 
was determined for 10 antimicrobials according to NCCLS recom- 
mendations. Antimicrobials assayed were: ampicilhn (AMP), amoxi- 
ch/clavulanate (AMC), cefotaxjme (CTX), imipenem (IMP), ery- 
thromycin FRY), azithromycin (AZI), cotrimoxazole (SXT), ri- 
fampin (RIF), ciprofloxacin (CIP) and chloramphenicol (CHL). 
Results: Beta-lactamase producer strains predominated in blood 
(47%) and otical and conjunctival swabs (44% and 37%) and were less 
frequent in respiratory tract (25%) and other sites of isolation (17%). 
Table shows resistance evolution (in %) for all isolates: 
Haemophilus spp in a Five Years Period 
Year Sua~m AMP AMC CTX IMP ERY AZ1 S X T  CIP 
1991 241 36 3 0.8 - 37 - 75 - 
1992 264 32 0.7 0 0 53 - 67 0 
1993 222 36 3.5 0.9 0.9 81 4 53 2 
1994 173 29 1 0.5 0.5 92 0.5 46 1 
1995 104 36 3 0 0 96 2 52 1 
Conclusions: Antimicrobial resistance Haemophilus spp. showed 
no si&icant variation during the study period, with the exception 
of ERY which showed an increasing trend and SXT and RIF with 
a decreasing trend. We also remark the emergence of strains resistant 
to CTX, IMP and CIP during this period. 
Characterization of Neisseria meningitidis 
Strains Isolated from Cerebrospinal Fluid of 
Meningitis Patient in Poland During the Last 
Two Years 
W. Grzybowska ', I. Lind ', S. Tyski ' . ' Dmg Institute, Warsaw, 
Poland, 'Statens Serum Instituf, Copenhagen, Denmark 
Epidemiological data concerning N .  meningitis infections have been 
collected in Poland since 1970. Regular bacteriological monitoring 
of meningitis cases causes by N. meningitidis started in Poland two 
years ago, due to EMGM cooperation. Thirty one meningococcal 
s t r a i n s  isolates were collected in 1995 (20% registered cases) and 
66 in 1996 (47% registered cases) respectively. All together strains 
were isolated from cerebrospd fluid taken fium meningitis patients 
hospitalised in 54 units located in 33 out of 49 districts of Poland. 
Most of the patients were below 2 years old (43% below 1 year). 
The predominant meningococcal serogroup was -B (79.3% of all 
isolates), then serogroups C (12.6%), W-135 (3.5%), and A (2.3%). 
Only two isolates were notgrupable. Most (59.4%) of the isolates 
B group and two C were typable by monoclonal antibody "22", 
recently prepared in Czechs NFX for Meningococcal Infections. 
These results indicate the epidemiological and chical sigmficance 
of new serotype "22" in Central Europe countries. Two isolates 
of phenotype N .  merlingitidis C:2a:P1.2, 5, sulphonamide sensitive, 
whxh cause epidemic in Czech Republic in 1993, were isolated in 
the South of Poland recently. The most fxequent phenotype found in 
the last two years in Poland was N. meningitidis B:22:NST. Sensitivity 
of strains to selected antimicrobial agents was also examined. No 
penicillin resistant s t r a i n  (MIC >1.0 mg/L.) was found among Polish 
isolates. All strains were susceptible to ciprofloxacin (MIC 50.016 
mg/L), cefotaxime (MIC (0.04 mg/L), rifampicin (MIC 50.06 
mg/L), tetracycline (MIC 50.5 mg/L) and chloramphenicol (MIC 
- (2.0 mg/L). Some strains were resistant to sulphametoxazole (57.6% 
- MIC = 32 mg/L and 14.2% - MIC = 128 mg/L) what is assumed 
to be associated with widely distribution of this antimicrobial agent 
in Poland. 
I P7401 Increasing Antibiotics Resistance in Clinical 
Isolates of Haemophilus influenze in Taiwan 
M.L. Chu, H.C. Lin, C.C. Wang, C.M. Yu. Pediahics and 
Microbiology Research Lab. National Dpfpnse Medical Center, Zipei, 
Taiwan, ROC 
Objectives: To determine the prevalence of antimicrobial resistance 
of H. infuenzue isolated from Taiwan (1994-1995) 
Methods: 300 clinical isolates of H .  infuenzae obtained from 
10 hospitals throughout Taiwan during June 1994 to April 1995 
were examined for, serotype, B-lactamase production and antibiotic 
susceptibility test (NCCLS microdilution broth method) 
Results. Twenty three strains (7.7%) were type b. The remain- 
der were nontypable. The overall rate of B-lactamase production 
was 57.3% (172/300). Among 128 B-lactamase-negative H .  infuen- 
zae isolates, 30 (10%) were resistant to a m p i c h .  The resistant 
rates to ampicillin, trimethoprim-sulfmethoxazole, chlorampheni- 
col, tetracyche, and azithromycin, were 67.3%, 34.3%, 20.3% 27%, 
and 44.3%, respectively. In contrast, the second and third gener- 
ation cephalosporins and ciprofloxacin remained active against H .  
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infuenzae. A sigmficant number of strains were resistant to multiple 
antibiotics: 10.7% to three antibiotics (ampicillin, chloramphenicol, 
and tetracyche) and 5.3% to four anabiohcs (ampidh ,  chloram- 
phenicol, tetracycline, and trimethoprim-sulfamethomole). 
Conclusions: There was a sigmficant increase of ampicillin 
resistance and /3 lactamase production compared to a previous 
survey in Taiwan conducted nine years ago. The prevalence of 
non-&lactamase-medmed ampicillin resistance (10%) and multiple 
resistance was markedly high. 
chloramphenicol, 98% to CFX, 92% to CTX, and 96% to cefurox- 
ime. Of the 33 Nm strains tested, 1 (3%) was resistant to penidin, 
1 to cefuroxime and 1 to CTX, but all were susceptible to CFX, 
chloramphenicol and ampicillin. 
Conclusion: CFX without vancomycin f ampicillin at extremes 
of age is a rational treatment of community-acquired meningitis. 
Other invasive mfections caused by Sp, Hi and Nm can be treated 
by cefuroxime as well. 
1 P741 I Effect of a New Monobactam on the Human 
Intestinal Microflora and the Occurrence of 
Beta-Lactamase Activity in Faeces 
M. Hedberg. C E  Nord, Huddinge University Hospital, Karolinska 
Institute, Stockholm, Sweden 
Objectives: To evaluate the effect of a new monobactam on the 
human intestinal microflora, the beta-lactamase activity and the con- 
centration of the antibiotic in faeces before, dunng and after treat- 
ment. 
Methods: Faecal samples h m  31 healthy volunteers divided in 
four groups, each group receiving Werent doses of a new monobac- 
tam, were investigated. Doses of 250 mg (group 1; n = 8), 500 mg 
+up 2; n = 8). 1000 mg (group 3; n = 8) and 2000 mg (group 
4; n = 7) administered intravenously were given every 6 hours for 7 
days. Stool samples were collected at days 0, 3, 5,7, 14 and 21. 
Resultc Administration of the monobactam resulted in a de- 
crease of E .  coli and other enterobacteria and overgrowth of en- 
terococci. Clostridium d f i l e  was found in six  persons. In 14 of 
the 31 volunteers concentrations of monobactam could be detected 
in faeces during treatment. When the substance was detected, this 
finding was correlated with a decrease in the number of Bacteroides 
sp. Beta-lactamase was found in almost all samples. The peak of 
beta-lactamase activity occurred after the peak level of monobactam 
and was correlated with growth of Baaeroides sp., and it is likely that 
the main beta-lactamase producers are kteroides sp. 
Conclusions: The adrmnistration of the new monobactam 
caused disturbances in the intestinal microflora and beta-lactamase 
producing bacteria were selected or induced during the treatment. 
The beta-lactamase producers belonged to Bademides sp. 
I P743 I Escherichia coli Resistance to Amoxicillin and 
Co-Amoxiclav in a Community with High 
Aminopenicillins Consumption Rate 
A. Torres 
A. Torrellas3, L. Agu~lar'. 'Surgery and Microbiology Dpt. ,  H .  San 
Carlos, Madrid, Spain, zSurgery and Microbiology Dpt . ,  H .  Principe de 
Asturias", Ahli de Henares, Madrid, Spain, 3Medical Dpt. SmithMine 
Beecham Pharmaceuticals, Madrid, Spain 
The antimicrobd susceptibility, following NCCLS methodology, 
to 96 E .  coli s t r a i n s  isolated from 94 patients with complicated 
intra-abdominal infections (colectomy, appendicectomy, gastrec- 
tomy, laparotomy and cholecystectomy) or urinary tract infections 
(UTI) acquired in surgical wards, to amoxi&, co-amoxidav 
(2: l), cefuroxime and cefotaxime was performed during the period 
March-November 1994. 
The dstribution of isolates with respect to the source of infection 
were: appendix (35.5%), bladder (17.25%), caecum/colon/rectum 
(10.8%), lower UTI (16.1%), pyelonephritis (1.1%) and others 
(10.8%). According to the type of sample distribution was as follows: 
peritoneal fluid (58.1%), abcess material (22.6%), urine (16.1%) and 
others (3.2%). 
Using NCCLS breakpoints (1993), 43.8% of s t r a i n s  were suscep- 
tible to amoxicillin, 89.6% to co-amoxidav, 93.8%, to c e h x i m e  
and 100.0% to ceforaxime. Of 15 strains coming h m  UTI, only 
one showed an MIC of 32 mcg/ml against co-amoxichv. 
The high amoxicillin resistance rate of these strains is sigmficantly 
reduced when clawlamate is added to the susceptibility test. The 
co-amoxiclav resistance rate (4.2%) obtained in our country is similar 
to the one obtained in other European centers, even though Spain 
has one of the highest E .  coli aminopenicillins resistance rates in the 
European Union. 
E de la Torre M. Diez-Alonso * , J. Romanyk', 
I P742 ] Antimicrobial Susceptibility of lnvasive Isolates 
of H. lnfluenzae (Hi), N. Meningitidis (Nm) and S. 
Pneumoniae (Sp) in Slovenia 
M. eikman, M. Paragi, M. Gubina for the Slovenian Meningitis 
Study Group. Uniwrsity Medical Centre, Ljubljana, Slovenia 
Background The increasing antimicrobial resistance of these 
pathogens provided the rationale for a surveillance study evaluating 
the prevalence of resistant strains in Slovenia. 
Methods: Sp, Nm and Hi isolates h m  children aged 0-14 years, 
recovered from normally sterile body sites h m  1993 to 1995 were 
tested for susceptibility to antibiotics. Sp and Hi isolates were eval- 
uated using NCCLS disk a s i o n  methods. All Sp strains showing 
reduced susceptibility to penicillin on screening with a 1 wg oxacillin 
dsk were evaluated by the E test for resistance to penicillin, cefo- 
taxime (CFX) and ceftriaxone (CTX). Antimicrobial susceptibility 
of Nm strains was evaluated by the disk a s i o n  method. 
Results: hfty-two Sp strains, 52 Hi strains and 33 Nm strains 
were tested. Ofthe 52 Sp strains, 19% showed intermediate resis- 
tance to penicillin, all were sensitive to CFX, CTX and cefumxime, 
and 96% were sensitive to chloramphenicol. Of the 52 Hi strains, 
8 (15.3%) were betalactamase positive, and 98% were susceptible to 
lp744] Antibiotic Consumption Associated with the 
Prevalence of Antimicrobial Resistance among 
Clinical Isolates of E. coli 
T.G. Jensen. Department of Clinical Mbobiology, Odense Uniuersity 
Hospital, Denmark 
Objectives: The relation between antibiotic consumption and 
prevalence of antimicrobial resistance was examined for clinical iso- 
lates of Escherichia coli from 16 departments at a university hospital. 
Methods: The resistance patterns of all &cal isolates of E .  coli 
from 16 departments at Odense University Hospital, Denmark, were 
registered during a 6 year period (1987-1992). 7861 isolates from 
the patients third day of hospitalization or later were included in this 
analysis. Antibiotic usage was expressed as Defined Daily Doses per 
100 bed days. 
At department level stepwise multivariable weighted regression 
analysis was used to correlate the prevalence of resistance to the 
antibiotic usage and to the patients mean duration of hospitalization. 
Results: When the departments were compared, the prevalence 
of resistance against commonly used antibiotics was positively associ- 
ated with the usage of the antibiotic in question. The prevalence of 
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resistance against rarely used antibiotics was not associated with the 
usage of the antibiotic in question, but was instead positively associ- 
ated with the summed usage of the other antibiotics and the patients 
mean duration of hospitalization at the department. 
Conclusion: DiEerences in the prevalence of antimicrobial resis- 
tance of E. coli among hospital departments were associated with the 
antibiotic consumption and the patients mean length of stay at the 
departments 
[p745) Antimicrobial Resistance of Shigella flexnen’and 
Shigella sonneiin Hong Kong 1986-1995 
YW Chu’, E. Houang’, J.M. Ling’, D.J. Lyon’, T.K. Ng’, 
A.F.B. Cheng I .  ’ T h e  Chinese University of H K ,  Hong Kong, 2pn‘ncess 
Margaret Hospital, Hong Kong 
Objectives: To examine the change in patterns of antimicrobial 
resistance to 19 antibiotics of S. flexnen’ and S. sonnei in the past 
decade. 
Methods: We studied 334 S. flexneri and S. sonnei isolated dur- 
ing 1986 to 1995. The MICs of ampicdm (AMP), amoxycilhn 
with clavulamc acid (AMC), piperacillin (PIP), imipenem (IMI), 
cefepime (CPM), cefotaxime (CFX), ceftazidime (CTZ), cebrox- 
ime (CXM), amikacin (A), gentamicin (G), netilmicin (N), nalidixic 
acid (Nx), ciprofloxacin (CIP), ofloxacin (OFL), sparfloxacin (SPA), 
tetracycline (T), chloramphenicol (C), trimethoprim (Tm) and sul- 
phamethoxazole (Sm) were determined by the agar dilution method. 
The presence of the most common Ser-83 mutation in the gyrase A 
gene was determined by a previously described PCR method. 
Results: Of the 223 1986-95 S. Jexneri isolates, there was a sig- 
nificant increase in the MICs of all antibiotics tested. Isolates with 
Nx MICs 132  mg/L accounted for 57% (55/94) of 1994-5 collec- 
tion. All showed gyrase mutation. Their MICs of T, Tm, Sm, C, 
G, IMI, CPM, AMC were sigruficantly higher than those of con- 
temporaries without the gyrase mutation. Ofthe 111 1986-1995 S. 
sonnei isolates, there was a significant increase in the MICs of CPM, 
CTX, CTZ, IMI, Nx, CIF’, OFL, SPX, Sm and Tm. By 1995, the 
MICs of all antibiotics of S. Jexneri were significantly higher than 
those of S. sonnei, with the exception of Sm. 
Conclusion: In the past decade, Hong Kong isolates of S. Jexnm’ 
and S. sonnei have shown a significant increase in their MICs of 
antimicrobial agents some of which have not been commonly used 
for gastroenteritis. 
Pseudomonas aeruginosa - Trends in Antibiotic 
Resistance in Bratislava Hospitals 
M. Ketmer *, J. Kallovl’, H. Bujdikovi’. St. Publ. P. MdoSoviE 
Health Inst., Bratislava, Slovakia, ’Dept. ofhlinobiol. and Krol., 
Comenius Uniu., Bratislava, Slouuleia 
Nosocomial infections caused by P aeruginosa have been a major 
problem in hospitalized patients. Our study presents the occurence 
of antibiotic resistance of I? aeruginosa isolates from 6 Bratislava hospi- 
tals, mainly from ICUs, Urology, Paediatry and Surgery Departments 
in the period 1991-1996. Amikacin resistance increased &om 4.0% 
in 1991 to 28% in 1996. Ceftazidime resistance was 1.4% in 1992 
and 23% in 1996. With ciprofloxacin an increase &om 2.3% re- 
sistance in 1991 to 35% in 1996 was observed. The highest rate 
of resistance was found in strains isolated b m  urine. In 1996, 
resistance to meropenem was 40%. piperac&h/tazobactam 20%, 
azlocilin 40%. tobramycin 43%, ofloxacin 45%, nehlrnicin 53% and 
cefotaxime 62%. We observed the frequent occurrence of serogroup 
01 1, which is often associated with the multiple resistance. Mecha- 
nisms of such resistance to aminoglycosides was due to the produc- 
tion of aminoglycoside modifjmg enzymes (AAC (6’)-I and APH 
(2”)), to beta-lactams was caused by beta-lactamases. Several strains 
showed impermeabhty. Its evident that resistance of P aeruginosa 
strains to a wide spectrum antibiotics increased considerably. 
Antibiotic Susceptibilities of Gram-Negative 
Rods from Blood or CSF 
D.C.E. Speller’, A.P. Johnson, R.C. George, D. James. Central 
Public Health Laboratoty, Colindale, London, UK 
Objectives: To monitor resistance trends. 
Methods: C h c a l  laboratories throughout England and Wales 
report results obtained by their own methods. The National Quality 
Assessment Scheme provides general QA. Statistical significance: p 
< 0.05; chi’ for trends. 
Results: In 1989-94, >10,000 unique patient episodes per year 
were analysed. In most genera, resistance rates to ampicillin and 
gentamicin were stable. Overall, imipenem showed least resistance. 
There were sigdicant trends to increased resistance to ciprofloxacin 
in Escherichia, Mebsiella, Enterobacter, Serratia and Pseudomonas aerugi- 
nosa, to trimethoprim in Escherichia, Klebsiella, Enterobacter and Serra- 
tia, and to ceftazidme in Klebsielln and Enterobactex However, most 
isolates remained susceptible. In 1994, percentages susceptible to 
ciprofloxacin were Escherichia 98.3, Klebsiella 93.5, Enterobacter 92.9, 
Serratia 84.8 and I? aeruginosa 92.7; to trimethoprim Eschm’chia 75.3, 
Mebriella 72.9, Enterobacter 78.2 and Serratia 38.6; and to ceftazidime 
Klebsiella 94.3 and Enterobacter 73.5. 
Conclusions: Sigmficant trends to resistance have occurred, but 
absolute resistance rates do not indicate a need for major antibiotic 
policy changes 
1 P748 1 Epidemiological Markers and Aminoglycoside 
Resistance Mechanisms (AgRM) in 
Pseudomonas aeruginosa (PA) Multiresistant 
Strains 
I. Galani, G. Petrikkos, V. Grecka, E. Xirouchaki, E. Sabatakou, 
M. Grammatikou, H. Giamarellou. Athens University School of 
Medicine, Athens, Greece 
Objective: Multiresistant PA is a major cause of m o r d t y  partic- 
ularly in the immunocompromised host. S i m h  strains as a rule 
predominate in several tertiary hospitals. To apply correct hygienic 
measurement it is very important to clarlfy if one or several clones 
are found. 
Methods: 22 (8.7%) out of 254 PA strains collected &om 35 
Greek hospitals, in 1994 were found resistant to all antipseudomonal 
antibiotics. Serotyping (DIFCO set) and typing by cell envelope 
proteins (CEPs’) study, were performed. Their AgRM’s were deter- 
mined with the AgR phenotypes to 12 Ags. 
Results: Among the 22 strains studied the most common serotype 
was 012 with four Merent CEPs’ profdes. Other predominants 
serotypes were the 011, 05, 01 & 02. Five single AgRM occured 
in 3 combinations. A permeability problem to all Ags was detected 
in 18 strains while AAC (6’)-11, AAC (3’)-I1 and APH (3’)-I enzymes 
were detected in 19 strains, and AAC (3)-I was found in 4 strains. 
The most common combination was permeabihty + AAC (3’)-I1 + 
AAC (6’)-I1 + APH (3’)-I (68%). The combination of AAC (3’)-I + 
AAC (3’)-I1 + AAC (6‘)-I1 + APH (3’)-I was detected in 4 strains 
(18%) while permeability was the only cause of resistance in only 3 
strains (14%). 
Conclusion: The detected Ags mechanisms were similar to those 
foundinpreviousstudies ofour group (J Chem7 (S2): 17,1995). No 
correlation between epidemiological typing and AgRM was found. 
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lp749] Proteus and Providencia. Incidence and 
Antibiotic Sensitivity 
W Amhis, M. Naim, D. Tiouit. Hopital Central de I'ArmCe Kouba 
Algeet; Algm'e 
Objectives: To evaluate the species incidence and their sensitivity 
to the antibiotic of the strains isolated fium 1994 to 1996. 
Methods: The strains are isolated fium patients specimens, iden- 
died with the AF'I galleries and their sensitivity tested with the 
antibiotic &ion technique. 
Results: 453 strains were isolated (439 Proteus and 14 Providemu). 
The species incidence is l? mirabilis (70.3%, I! morgrnii (16.8%), I! 
vulgaris (6.8%) and l? rettgm' (5.9%). The antibiotic sensitivity pattern 
of proteus genus sic showed resistance of most of the organism to 
Ampicilline, Amoxicilline +Cla&que. Ac, Cefalotine, and gen- 
tamycine and sensitivity to Cefotaxime, Netilmycine, Amikacine Pe- 
floxacine. The providencia is resistant only to Ampicilline. 
Conclusion: I! mirabilis is much more frequently isolated fium 
clinical specimens (70.3%) than the other species. 
The providencia genus is not frequent (only 14 strains were isolated 
through the three years) and remains sensitive to the antibiotics tested 
except for ampicilline (85.7% of resistance). 
[ E l  Exclusion of Duplicate Isolates does not A M  
Measured Resistance Rates 
WR. Gransden, K.F? Shannon. Department ofMicrobiolofl, UMDS,  
Guy's 6. St Thomac' Hospitals, London, UK 
Objectives: To assess the effect of exclusion of duplicate iso- 
lates on the analysis of antimicrobial susceptibility patterns of mi- 
cro-organisms from patients in an adult Intensive Care Unit (ICU). 
Methob. The resistance patterns, based on disc susceptibility 
testing, of all bacterial and fungal isolates fium routine microbiology 
samples from patients in ICU were obtained from the Microbiology 
Laboratory Computer. A computer algorithm was used to exclude 
duplicate isolates. A duplicate isolate was defined as one of the same 
species and susceptibhty pattern isolated fiom a single patient within 
a period of 30 days. Results were compared with and without the 
exclusion of duplicate isolates. The statistical sigruhcance of Wer- 
ences in percentages were assessed by calculation of 95% confidence 
intervals. 
Results: During 1995, 2453 isolates were obtained. Of these, 
1093 (45%) were duplicates. Duplicate isolates were more frequent 
among Senaria spp (72%), MRSA (65%), and other Staph. auras 
(59%) and less frequent among Steno. maltophilia (18%), Acinetobac- 
ter spp (23%). When results for all isolates were compared with 
those for unique patient isolates no sigdicant Werence was ob- 
served between any resistance rates, in particular those of gentamicin, 
azlodh, imipenem, ceftazidime, ciprofloxacin, amoxycih and 
trimethoprirn in Gram-negative species, of penicillin, methicillin, 
gentamicin, vancomycin, rifampicin, and fusidate in Gram-positive 
species and of fluconazole for Candida spp. 
Conclusions: Although bacterial species vary in their propensity 
to persist in patients in our ICU, measured resistance frequencies (for 
guidance on empirical therapy) are not affected by the exclusion of 
duplicate isolates. 
I P751 I Selection Pressure of Previous Antibiotherapy 
and/or Hospitalisation of Streptococcus 
pneumoniae (Sp), Haemophilus influenzae (Hi) 
and Moraxella Catanhalis (Mc) Isolated from 
Adult Patients with a Lower Respiratory Tract 
Infection (LRTI), in Europe 
'L! Jarlier, C. Carbon, R. Wise. Hapita1 Salp6tri&, Paris, France, CHU 
Bichat Claude Bernard, Paris, France, City Hospital N H S  Twt, 
Birmingham, England 
Objective: To investigate the selection pressure of Sp, Hi, Mc iso- 
lated in adult community-acquired LRTI. 
Methods: A multicenter study was implemented between De- 
cember 1994 and 1995 in France (F). Germany (D), Great Britain 
(GB), Hungary (H), Ireland (IRL), Italy (I) the Netherlands (NL), 
Portugal (p), Slovakia (SK) and Spain (E). The betalactamase produc- 
tion and MICs of p e n i c h  (pen), erythromycin (Er), tetracycline 
(Te) and spadloxacin (Spx) were determined (using cefinase &cs 
(Hi, Mc), agar diffusion E test (H, IRL), agar dilution (GB) and 
broth microdilution using microplates. Resistant Sp (R-Sp) were 
defined as non susceptible to Pen and/or Er and/or Te and/or Spx; 
resistant Hi and Mc @-Hi, R-Mc) were betalactamase producen 
and/or non susceptible to Te and/or Er (Mc only). A positive selec- 
tion pressure (pr+) was defmed by an antibiotic prescription and/or 
hospitalisation during the month prior to the patient LRTI. 
Results: A total of 1872 s t r a i n s  (572 Sp, 991 Hi, 309 Mc) were 
isolated from acute exacerbation of chronic bronchitis (AJXB: 51%). 
pneumonia (PN: 17%) or chest infection (CI: 32%). No Hi and Mc, 
and only 5 Sp (0.9%) were resistant to Spx. Resistance was more 
frequent (p < 0.05) in Pr+ strains (in Pr+ Sp, but not in PI+ Hi and 
Mc): 
Pr+ Pr- 
Sp + Hi + Mcn = 492 
R-Sp + R-Hi + R-mcn = 326 
n = 1380 
n = 811 
Conclusion: The most sqmficant Pr+ was found with 
macrolides. Pr+ was between 15% (NL) and 49% (SK), and less 
frequent in CI (22%) than in AECB and PN (28%). 
Malaria 
Lp75?1 An Open Comparative 28 Day Trial of CGP 56697 
(2 Days) versus Oral Quinine (8 Days) in the 
Treatment of Acute 6 hlciparum malaria in Thai 
Children 
A. Sabchareon ' , F? Attanath ', I. Gathmann *, R. Mull *, 
I? Chanthavanich 
C. Royce', F? Phanuaksook', F! Kanjanapipatku13, 
S. Bounyasoung4, Y. Poonpanich5. 'Mahidol University, Bangkok, 
Thailand, 2Novattis Ltd., Basel, Switzerland, 'Mae Sot Hospital, Tak 
Province, Thailand, 4Srisangvalaya Hospital, Mae Hong Son Province, 
Thailand, ' Thongphaphum Hospital, Kanchana Bun Province, Thailand 
Treatment groups: 219 children were randomly assigned to oral 
treatment with CGP 56697 for 48 hours (n = 111) or quinine 
for 8 days (n = 108) in three rural centres in Thailand. 
Trial population: Children w e e g  >10 kg with uncom- 
plicated I! fakipaturn malaria. Median baseline paasitaemia was 
48,145IpL (Centre 1: 47,55O/pL; Centre 2: 89,55O/pLL; Centre 
3: 21,4OO/fiL). 
C. Sirivichayakul', C. Poiamen-anant ', 
